AstraZeneca's stock has seen its fair value estimate rise from $134.64 to $138.16 as analysts update their outlook for the ...
TETRA Technologies stock has seen a modest increase in its consensus analyst fair value target, rising by $0.50 to $6.83 per share. Analysts cite renewed confidence in the company’s long-term growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback